Arcturus Therapeutics

Founded in 2013 and based in San Diego, Arcturus Therapeutics, Inc. (NASDAQ:ARCT) is an RNA medicines company with enabling technologies – UNA Oligomer chemistry and LUNAR® lipid-mediated delivery. Arcturus’ diverse pipeline of RNA therapeutics includes programs pursuing rare diseases, Hepatitis B, non-alcoholic steatohepatitis (NASH), cystic fibrosis, and vaccines. Arcturus’ versatile RNA therapeutics platforms can be applied toward multiple types of RNA medicines including small interfering RNA, messenger RNA, replicon RNA, antisense RNA, microRNA and gene editing therapeutics. Arcturus owns LUNAR® lipid-mediated delivery and Unlocked Nucleomonomer Agent (UNA) technology including UNA Oligomers, which are covered by its extensive patent portfolio (140 patents and patent applications, issued in the U.S., Europe, Japan, China and other countries). Arcturus’ proprietary UNA technology can be used to target individual genes in the human genome, as well as viral genes, and other species for therapeutic purposes. Arcturus’ commitment to the development of novel RNA therapeutics has led to partnerships with Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, Ultragenyx Pharmaceutical, Inc., Takeda Pharmaceutical Company Limited, Synthetic Genomics Inc. and the Cystic Fibrosis Foundation. For more information, visit, the content of which is not incorporated herein by reference.

Arcturus Therapeutics, Inc. is presently recruiting outstanding candidates with experience in the field of RNA technologies and nanoparticle sciences. Our corporate culture is dynamic, diverse, and creative. We value collaboration and teamwork. We seek individuals to join us with a genuine passion for the science behind helping to cure disease and improve the lives of patients. Please email your resume to


Senior Scientist, Translational Biology (Immunology)

Position Description:

Arcturus Therapeutics is seeking an innovative and highly motivated Immunologist to join our Translational Biology team. Our successful candidate will help build a new class of immune-therapy products based on Arcturus’s proprietary Lipid Nano Particle (LNP) nucleic acid delivery platform and must have strong expertise in immunology and effector cell biology.

In this role, you will be responsible for leading oncology and immunotherapy projects and identify and interrogate immunomodulatory target pathways using cutting-edge technologies and novel approaches to enrich our company pipeline. You will be responsible for supporting existing immunology-based programs including cancer vaccines and immunotherapy targeted projects.

Our successful candidate will thrive in a proactive, fast-paced ‘can-do’ culture and enjoy collaborating across the full range of development activities and project teams for the ground-breaking, mRNA-based new drug candidates targeting rare disease. Our candidate should have extensive laboratory research experience and a desire to continue in a laboratory-focused role with a high level of experimental vigor and quality. Prior experience with rodent tumor immunotherapy models, nucleic acid vaccine development, cancer immunology and immunotherapy is strongly preferred.



Vice President, Clinical Development, Rare Disease

Position Description:

Arcturus is seeking an experienced physician scientist to lead drug development for our mRNA-based programs. In this role, you will have direct medical responsibility for our rare disease development programs, including creating overall clinical development plans, designing clinical studies, writing protocols, ensuring timely execution and medical monitoring in close collaboration with Arcturus’s internal research and platform organizations and relevant external pharmaceutical partners. Reporting to the Chief Scientific Officer, the VP will work collaboratively with other senior and functional leaders to ensure integrated development strategies, and to drive portfolio prioritization. He/she will maintain a blend of strategic and operational accountabilities and will serve as an Arcturus spokesperson in external interactions with health authorities, at scientific meetings, and working with collaborators.

Our successful candidate will thrive in a proactive, fast-paced ‘can-do’ culture and enjoy collaborating across the full range of development activities for the ground-breaking, mRNA-based new drug candidates targeting rare disease. As a technically adept and agile drug developer, the VP will play a central role in advancing and expanding the Company’s already exciting and diverse portfolio of products.



We thank all applicants for their interest. However, due to the volume of applications we receive, only shortlisted applicants will be contacted.